Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

[1],4-8,20] This might be due to differences in ... [4,5,6] Only a few patients had signs or symptoms of neuropathy. They were mainly in the form of distal sensory loss, parasthesias, absent ...

7. Influence of genetic and environmental factors on neuro-immune interactions in peripheral neuropathy. 8. Development and evaluation of novel therapeutic strategies targeting neuro-immune pathways ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...

Diabetes is a lifelong condition that causes your blood sugar levels to become too high - and some of the warning signs can ...

The Company is further eligible to receive up to an additional $8 million based on future milestones ... being developed as a potential treatment for acute and chronic neuropathic pain secondary to ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

In March 2023, my 94-year-old mother had a shingles episode on the right side of her neck, head, ear and (to a lesser degree) ...

The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...